Načítá se...
Early Predictors of Anemia in Patients with Hepatitis C Genotype 1 Treated with Peginterferon alfa-2a (40KD) plus Ribavirin
OBJECTIVE: Adherence to ribavirin is one factor that is critically important in the treatment of hepatitis C virus infection. However, ribavirin can be associated with clinically significant hemolytic anemia resulting in dose modifications in up to one-quarter of patients. Currently, baseline predic...
Uloženo v:
| Hlavní autoři: | , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2008
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2752675/ https://ncbi.nlm.nih.gov/pubmed/18796095 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1572-0241.2008.01957.x |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|